Forty Seven Inc. Email Format
Biotechnology ResearchUnited States51-200 Employees
With a passion for helping patients defeat their cancer, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.